CLOSTRIDIUM DIFFICILE INFECTION
Clinical trials for CLOSTRIDIUM DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIUM DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop transplant plus drug: a powerful combo to fight a stubborn gut infection?
Disease control CompletedThis study tested if adding a drug called bezlotoxumab to a fecal microbiota transplant (FMT) works better than FMT alone to prevent C. difficile infection (CDI) from coming back. It involved 61 adults with inflammatory bowel disease (IBD) who kept getting repeat CDI. Participant…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Study aims to stop the revolving door of c. diff infections
Prevention CompletedThis study tested if adding a two-week tapering dose of the antibiotic vancomycin after the standard 14-day treatment could prevent C. difficile infection (CDI) from coming back. It involved 263 adults who had just finished treatment for their first or second CDI. Participants we…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION
Phase: PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Mar 20, 2026 14:47 UTC